Neuromodulation of Mind-Wandering in Depression
NCT: NCT04832685 · ACTIVE_NOT_RECRUITING
Brief Summary
The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of LIFUP in changing negative cognition in depression. Specifically, the investigators will study if modulating DMN activity can change maladaptive mind-wandering. The investigators hypothesize that DOWN-modulation of the posterior cingulate cortex (PCC), a key DMN node, will decrease DMN resting state functional connectivity, perfusion, and activation during a cognitive-affective task (description below). The investigators also hypothesize that DOWN-modulation of the PCC will be associated with decreased mind-wandering and increased mindfulness. Finally, the investigators hypothesize that the opposite will be true for UP-modulation of the PCC.
Frequently Asked Questions
What is Neuromodulation of Mind-Wandering in Depression?
Neuromodulation of Mind-Wandering in Depression is a clinical trial registered under NCT04832685. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04832685?
The current status of NCT04832685 (Neuromodulation of Mind-Wandering in Depression) is: ACTIVE_NOT_RECRUITING.
When did Neuromodulation of Mind-Wandering in Depression start?
Neuromodulation of Mind-Wandering in Depression started on 2023-03-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.